Liver biopsy†
2008 · Hepatology · 1,914 citations
https://doi.org/10.1002/hep.22742
Z
Zachary Goodman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
470
Papers
62.0K
Citations
109
h-index
247
i10-index
Zachary Goodman is an academic researcher from Inova Fairfax Hospital. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Liver Diseases and Immunity. The author has an h-index of 109, co-authored 400 publications.
Papers by this author
worksObeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
2017 · Hepatology · 418 citations
https://doi.org/10.1002/hep.29721
Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial
2007 · Hepatology · 199 citations
https://doi.org/10.1002/hep.22094
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib
2018 · Journal of Hepatology · 196 citations
https://doi.org/10.1016/j.jhep.2018.09.024
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
2019 · Contemporary Clinical Trials · 123 citations
https://doi.org/10.1016/j.cct.2019.06.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat